Agenda

08.30

Registration, Networking & Breakfast

09.00

Welcome & Opening Remarks

Stephen Watson, Co-Founder & CEO, Founders Health

Phil Newman, CEO & Founder, Longevity.Technology

09:15

Consumer Diagnostics: Presentations and Q&A

This session will showcase a selection of the most exciting companies that are leveraging technology, data science, and AI to improve lifespan and healthspan on an individual and societal level. Learn how these technologies are helping improve healthspan and gain valuable insights from leading experts during a Q&A session.

The Convergence of AI and Epigenetics

Matthew Dawson, CEO, TruDiagnostic

Digital Longevity and Population Scale Health

Michael Geer, Co-Founder, Humanity

Moderator: Judith Mueller, Director, Single Family Office

10:05

Longevity Biohacking: Showcase 

Highlighting the latest in biohacking advances to enhance metabolism and replace cellular function lost with the progression of age. Through a series of dynamic presentations understand the latest advances in biohacking equipment and tracking effectiveness. 

Erin Lee, Founder & CEO, Touchless Wellness Association

The Application of Hormesis to Affect Change

Dr. Ash Kapoor, Medical Director, Levitas Group & CEO/COO, Levitas One

The Longevity Illusion: Expensive Hacks, Forgotten Wisdom, and What Really Moves the Needle

Tim Gray, Founder & CEO, Health Optimisation Summit

Moderator: Tamsin Lewis, Founder & Medical Director, Wellgevity

10:50

Refreshments & Networking

11:10

Blueprinting the Future: Bryan Johnson on Optimising Life and Defying Death

Bryan Johnson, founder of Blueprint and leader of the “Don’t Die” movement, joins us to share his bold vision for the future of ageing. He’ll discuss the evolution of Blueprint, the challenges of building in the longevity space, and how deep self-measurement is shaping new systems for health and performance along with a few unexpected insights from his personal journey.

Bryan Johnson, Founder & CEO, Blueprint

11:35

Regulation as an Enabler: Accelerating Innovation in Longevity Science  

A conversation on how regulators are adapting to support the pace of innovation in longevity biotech, diagnostics, and consumer health. This session will explore how regulatory frameworks are evolving to enable groundbreaking work in healthspan extension while ensuring public trust and safety.

Lawrence Tallon, Chief Executive Officer, Medicines & Healthcare products Regulatory Agency

Moderator:

Vishal Harnal, Managing Partner, 500 Global

11:50

Longevity Clinics: Presentations and Q&A

Spotlighting the opportunities around physical and digital clinics for the professional diagnosis of health and ageing biomarkers in addition to clinical guidance on lifestyle, diet and therapeutic interventions to mitigate the progression of age. Followed by audience Q&A. 

Why Your Biology is Your Biggest Business Asset

Stephen Watson, Co-Founder & CEO, Founders Health & Avi Roy, Chief Scientific Officer, Founders Health

Building a Digital and AI Clinical Network

William Kapp, Co-Founder & Chief Executive Officer, Fountain Life

The Future of Health Is Personal: Building the Luxury Operating System for Longevity

Faye Mythen, Consulting CEO, Reborne Longevity Ltd

Moderator: Joanna Bensz, Founder & CEO, Longevity Centre Europe

12:50

The Future of Consumer Longevity Investment: Panel Discussion and Q&A   

Bringing together a distinguished panel of top investors to explore the latest trends, emerging opportunities, and transformative technologies within consumer longevity investments. These experts are at the forefront of funding breakthrough companies that are reshaping the way we think about ageing, wellness, and healthspan extension.

Amol Sarva, Managing Partner, LifeX 

Antoine Attali, Chief Financial Officer, Zoī

Boyang, Founder, Immortal Dragons

Marc P. Bernegger, Founding Partner, Maximon

Moderator: Phil Newman, CEO & Founder, Longevity.Technology

14:35

Ageing Disease Prevention: Presentation & Panel Discussion 

In this session, we will explore the drivers of ageing with a presentation by Repair Biotechnologies, followed by an in-depth panel discussion on the latest clinical interventions aimed at controlling these drivers and preventing age-related diseases. The panel of leading experts will examine emerging therapies, cutting-edge research, and the potential for medical breakthroughs that could significantly delay or even prevent ageing diseases from manifesting.

Localised Cholesterol Excess: An Important Contributing Cause of Age-Related Disease

Reason, CEO, Repair Biotechnologies

Panel: 

Alexandra Bause, Co-Founder & Venture Partner, Apollo Health Ventures

Eric Morgen, Co-Founder & COO, BioAge

Reason, CEO, Repair Biotechnologies

Moderator: Todd White, Managing Director, The Thalion Initiative

15:15

Targeted Age Reversal: Presentations and Q&A

Exploring the latest therapeutic interventions that stop or reverse age-related damage in specific organs or for age-related diseases. Presentations on epigenetic and partial cellular reprogramming to restore cellular function followed by audience Q&A. 

Partial Cellular Reprogramming. 

Daniel Ives, CEO & Founder, Shift Bioscience

Epigenetic Reprogramming To Restore Cellular Function 

Sharon Rosenzweig-Lipson, Chief Scientific Officer, Life Biosciences 

Moderator: Stasa Stankovic, Reproductive Geneticist, University of Cambridge

16:05

Systemic Age Reversal: Showcase 

Introducing cutting edge therapeutic interventions that stop or reverse age-related damage throughout the whole body system. Including presentations from organisations at the forefront of the next frontier in regenerative medicine. 

Mitochondrial Transplantation for Systemic Age Reversal

Rachel Diamant, CEO and Co-Founder, Cellergy Therapeutics

Alternative Pathways to Systemic Rejuvenation

Patrick Burgermeister, General Partner, RegenEra Ventures

Moderator: Dame Molly Stevens, Professor of Biomedical Materials and Regenerative Medicine, Imperial College London

16:40

The Future of Biotech Longevity Investment: Panel Discussion and Q&A

Join leading venture capitalists as they explore the rapidly evolving landscape of biotech longevity investment. Discover how VCs are identifying game-changing startups and the key factors driving investment decisions in this high-growth sector. 

Gregory Bailey, Executive Chairman & Co-Founder, Juvenescence

Laura Deming, CEO, Cradle, Co-Founder & Venture Partner, age1, Founder, Longevity Fund

Will Harborne, Founding Partner & GP, LongGame Ventures 

Moderator: Phil Newman, CEO & Founder, Longevity.Technology

17:10

Closing Remarks from Founders Forum & Longevity.Technology

17:20

Close of Conference & Networking Drinks